Eurofins-Cerep SA Stock Price

ENXTPA:ALECR Community·€89.8m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

ALECR Share Price Performance

€17,800.00

-1800.00 (-9.18%)

€17,800.00

-1800.00 (-9.18%)

€17,800.00

Fri, 26 Dec 25

Share Pricen/a

ALECR Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Adequate balance sheet and slightly overvalued.

0 Risks

1 Reward

View Full Analysis

Eurofins-Cerep SA Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: 1.22k
: 46.51%
: 15.86%
: 0.1%

View Full Analysis

About ALECR

Founded: 1989
Employees: 207
CEO: Damien Vielliard
WebsiteView website: www.eurofins.fr/cerep

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company’s research services include compound management, and high-throughput screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.